Capvizr
THE DEAL, AT A GLANCE

FORE Biotherapeutics

From the announcement
01What happenedFORE Biotherapeutics raised $67.4M Series D, announced 2026-07-07From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersFORE Biotherapeutics' $67.4M Series D-2 extension is a mid-market Healthcare & Life Sciences financing that signals continued investor capacity for private biotech…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

FORE Biotherapeutics · Financing Record

Explore source-linked visual explanations for FORE Biotherapeutics. Unsupported claims are withheld while source review continues.

Record 7629 · Recorded date: 2026-07-07

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime